論文（英文）

• Fuyama K, Ogawa M, Mizusawa J, Kanemitsu Y, Fujita S, Kawahara T, Sakamaki K, Oba K. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons. Stat Med. 2023 Feb 27. doi: 10.1002/sim.9690. Online ahead of print.
• Yoshida C, Yamaguchi H, Doki N, Murai K, Iino M, Hatta Y, Onizuka M, Yokose N, Fujimaki K, Hagihara M, Oshikawa G, Murayama K, Kumagai T, Kimura S, Najima Y, Iriyama N, Tsutsumi I, Oba K, Kojima H, Sakamaki H, Inokuchi K; Kanto CML Study Group. Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study. Int J Hematol. 2023 Feb 4. doi: 10.1007/s12185-023-03549-3. Online ahead of print.
• Yamashina A, Nishikori M, Fujimito H, Oba K. Identification of predictive factors interacting with heart rate reduction for potential beneficial clinical outcomes in chronic heart failure: A systematic literature review and meta-analysis. Int J Cardiol Heart Vasc 2022;43:101141.
• Noguchi T, Ishihara S, Uchino M, Ikeuchi H, Okabayashi K, Futami K, Tanaka S, Ohge H, Nagahara H, Watanabe K, Itabashi M, Okamoto K, Okita Y, Mizushima T, Mizuuchi Y, Yamada K, Shimada Y, Sato Y, Kimura H, Takahashi K, Hida K, Kinugasa Y, Okuda J, Daito K, Koyama F, Ueno H, Yamamoto T, Hanai T, Maemoto A, Oba K, Ajioka Y, Sugihara K; Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon, Rectum. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease. J Gastroenterol 2023;58(1):14-24.
• Izumi S, Hagiwara Y, Matsuyama Y, Shiroiwa T, Taira N, Kawahara T, Konomura K, Noto S, Fukuda T, Shimozuma K. Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L. Health Qual Life Outcomes. 2023;21:3.
• Okada A, Yamada G, Kimura T, Hagiwara Y, Yamaguchi S, Kurakawa KI, Nangaku M, Yamauchi T, Matsuyama Y, Kadowaki T. Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic/glycemic abnormalities. J Diabetes Investig. 2022. https://doi.org/10.1111/jdi.13966 Online ahead of print.
• Matsumoto H, Hagiwara Y, Yamamoto-Mitani N, Igarashi A. A randomized control trial for ReDeSign: A dementia-friendly mobile microlearning training for store workers in Japan. Gerontologist. 2022 Dec 12;gnac182. doi: 10.1093/geront/gnac182. Online ahead of print.
• Takeuchi Y, Iwagami M, Ono S, Michihata N, Uemura K, Yasunaga H. A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan. Vaccine. 40(52) 7622-7630 2022 Dec.
• The Fact-finding Committee of the Japanese Society of Pressure Ulcers, Konya C, Takeuchi Y, Nakagami G, Kitamura A, Morita K, Ishizawa M, Abe Y, Higuchi H, Mizuki T, Motegi S, Shoju S, Shimada K, Tanaka K, Kawakami S, Sanada H. Nationwide time-series surveys of pressure ulcer prevalence in Japan. Journal of Wound Care. 31(Sup12) S40-S47 2022 Dec.
• Kikawa Y, Hagiwara Y, Fujisawa T, Araki K, Iwamoto T, Sangai T, Shien T, Takao S, Nishimura R, Takahashi M, Toyama T, Aihara T, Mukai H, Taira N. Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy. PLoS One. 2022;17:e0278344.
• Hagiwara Y, Shiroiwa T, Taira N, Kawahara T, Konomura K, Noto S, Fukuda T, Shimozuma K. Gradient boosted tree approaches for mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 onto 5-level version of EQ-5D index for patients with cancer. Value Health. 2022. doi: 10.1016/j.jval.2022.07.020. Online ahead of print.
• Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Okiyama N, Kodera M, Hasegawa M, Sato S. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 2022;4(8): e546 – e555. https://doi.org/10.1016/S2665-9913(22)00131-X
• Oba K, Kagiwada Y, Kamada M, Miki R, Kondo Y, Kamakura T, Yamagami T, Fujita T, Tsuchida Y. Evaluating the feasibility of a remote-based training program supported by information and communications technology in the older adults living at home. BMC Geriatr. 2022;22(1):574. doi: 10.1186/s12877-022-03273-3.
• Watanabe J, Maeda H, Nagasaka T, Yokota M, Hirata K, Akazawa N, Kagawa Y, Yamada T, Shiozawa M, Ando T, Kato T, Mishima H, Sakamoto J, Oba K, Nagata N. Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA. Int J Cancer. 2022 Jun 20. doi: 10.1002/ijc.34184. Online ahead of print.
• Nagata H, Kawai K, Oba K, Nozawa H, Yamauchi S, Sugihara K, Ishihara S. Laparoscopic Colectomy: A Risk Factor for Postoperative Peritoneal Metastasis. Clin Colorectal Cancer. 2022 May 18:S1533-0028(22)00057-3. doi: 10.1016/j.clcc.2022.05.003.
• Kawamoto Y, Yuki S, Meguro T, Hatanaka K, Uebayashi M, Nakamura M, Nakamura M, Okuda H, Iwanaga I, Kato T, Nakano S, Sato A, Harada K, Oba K, Sakata Y, Sakamoto N, Komatsu Y. Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201). Oncologist. 2022;27: 340–e374.
• Kemmochi M, Nawa Y, Ohno S, Sawashita Y, Terada H, Oba K. Analysis of the radial and ulnar arteries using ultrasound and a vascular visualization device in children. Paediatr Anaesth 2022;32(6):747-753. doi: 10.1111/pan.14434.
• Sawamoto R, Oba K, Matsuyama Y. Bayesian adaptive randomization design incorporating propensity score-matched historical controls. Pharm Stat. 2022 Mar 12. doi: 10.1002/pst.2203. Online ahead of print.
• Waki K, Shichijo S, Uedo N, Takeuchi Y, Maekawa A, Kanesaka T, Takeuchi Y, Higashino K. Ishihara R, Tanaka Y, Michida T. Long-term outcomes after endoscopic resection for late elderly patients with early gastric cancer. Gastrointest Endosc 95(5) 873-883 2022 May.
• Fujita S, Hagiwara A, Takei N, Fukunaga I, Hagiwara Y, Ogawa T, Hatano T, Rettmann D, Banerjee S, Hwang K, Amemiya S, Kamagata K, Hattori N, Abe O, Aoki S. Rigid real-time prospective motion-corrected three-dimensional multiparametric mapping of the human brain. Neuroimage. 2022;119176. doi: 10.1016/j.neuroimage.2022.119176. Online ahead of print.

TOP